Related Experiment Video

Updated: Jun 21, 2026

Single Cell Measurement of Dopamine Release with Simultaneous Voltage-clamp and Amperometry
07:30

Single Cell Measurement of Dopamine Release with Simultaneous Voltage-clamp and Amperometry

Published on: November 21, 2012

[Differences in neuronal toxicity and its molecular mechanisms between methamphetamine and methylphenidate]

Minoru Narita1, Megumi Asato, Keiko Shindo

  • 1Department of Toxicology, Hoshi University School of Pharmacological Pharmaceutical Sciences, 2-4-41 Ebara, Shinagawa-ku, Tokyo, 142-8501 Japan. narita@hoshi.ac.jp

Nihon Shinkei Seishin Yakurigaku Zasshi = Japanese Journal of Psychopharmacology
|August 12, 2009
PubMed

Insights

Methylphenidate (MPH) does not cause long-term behavioral sensitization or rewarding effects like methamphetamine (METH). MPH

Area of Science:

  • Neuroscience
  • Pharmacology
  • Cell Biology

Background:

  • Methylphenidate (MPH) treats narcolepsy and ADHD, sharing psychostimulant properties with methamphetamine (METH).
  • Repeated psychostimulant use can induce behavioral sensitization and reward effects.
  • Astrocytes play a crucial role in neuronal network function.

Purpose of the Study:

  • To compare the long-term behavioral and cellular effects of Methylphenidate (MPH) and Methamphetamine (METH).

Main Methods:

  • Assessing behavioral sensitization to hyperlocomotion in response to repeated drug administration.
  • Evaluating drug-induced rewarding effects and their persistence after withdrawal.
  • Investigating astrocytic activation in neuron/glia cocultures and primary neuronal cultures.
  • Analyzing neuronal cell viability and apoptosis markers (MAP2a/b, cleaved caspase-3).

Main Results:

  • Methamphetamine (METH) induced significant behavioral sensitization and long-lasting rewarding effects.
  • Methylphenidate (MPH) failed to induce behavioral sensitization and its rewarding effects were transient.
  • Both METH and MPH activated astrocytes, but METH-induced activation was persistent while MPH's was reversible.
  • High METH concentrations induced neuronal cell death, unlike MPH.

Conclusions:

  • Methamphetamine (METH) and Methylphenidate (MPH) exert their psychostimulant effects through distinct mechanisms.
  • METH exhibits a greater potential for inducing long-term neuroplastic changes and addiction liability compared to MPH.
  • Differential effects on astrocytes and neuronal survival highlight key mechanistic differences between METH and MPH.

More Related Videos

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration09:16

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration

Published on: January 22, 2016

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices07:56

A Plate-Based Assay for the Measurement of Endogenous Monoamine Release in Acute Brain Slices

Published on: August 11, 2021

Related Concept Videos

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
Stimulants01:29

Stimulants

Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral bioavailability, and...
Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not necessarily...